Associated Papers
Association of genetic polymorphisms NCF4 rs1883112, CBR3 rs1056892, and ABCC1 rs3743527 with the cardiotoxic effects of doxorubicin in children with acute lymphoblastic leukemia.
Gándara-Mireles JA et al.
Pharmacogenetics and Genomics, 2021
An Example of Personalized Treatment in HR+ HER2+ Long Survivor Breast Cancer Patient (Case Report).
Panebianco M et al.
Current Oncology (toronto, Ont.), 2021
34070464 (PubMed )
Supplement: curroncol-28-00184-s001.zip › curroncol-1167217-SI.pdf
Oxidative Stress-Related Gene Polymorphisms Are Associated With Hepatitis B Virus-Induced Liver Disease in the Northern Chinese Han Population.
Ma N et al.
Frontiers in Genetics, 2019
Genetic variability in the multidrug resistance associated protein-1 (ABCC1/MRP1) predicts hematological toxicity in breast cancer patients receiving (neo-)adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide (FEC).
Vulsteke C et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology, 2013
Association of anthracycline-related cardiac histological lesions with NADPH oxidase functional polymorphisms.
Cascales A et al.
The Oncologist, 2013
Germline genetic polymorphisms may influence chemotherapy response and disease outcome in osteosarcoma: a pilot study.
Windsor RE et al.
Cancer, 2012
Pharmacogenomics of cardiovascular drugs and adverse effects in pediatrics.
Visscher H et al.
Journal of Cardiovascular Pharmacology, 2011
Pharmacogenetics influence treatment efficacy in childhood acute lymphoblastic leukemia.
Davidsen ML et al.
Journal of Pediatric Hematology/oncology, 2008
Select a paper to view details